US-Based Mederi Approved to Market GERD Treatment in China

Mederi Therapeutics, a Connecticut medical device maker, received CFDA approval for its Stretta Therapy, a non-surgical treatment for chronic gastroesophageal reflux disease (GERD). The Stretta device delivers radiofrequency (RF) energy to the muscle between the stomach and esophagus, remodeling and improving the muscle tissue, which reduces the number of reflux events. Mederi will launch the product in China through its distribution partner, Beijing Kanglian Medical. More details.... Share this with colleagues: // //